Allscripts Healthcare Solutions Inc (MDRX):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Allscripts Healthcare Solutions Inc (MDRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10067
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Allscripts Healthcare Solutions Inc (Allscripts), formerly Allscripts-Misys Healthcare Solutions, Inc., is a provider of healthcare information technology solutions. The company’s major solutions include Electronic Health Records (EHR), Financial Management Solutions, Population Health Management solutions, and Precision Medicine/Consumer Solutions. The company also offers services such as consulting services, managed IT services, education, hardware and hosting services. Allscripts caters its solutions to retail pharmacies, pharmacy benefit managers, physicians, hospitals, governments, health systems, health plans, retail clinics, and post-acute organizations. It has clients in North America, Asia, Australia, the Middle East and the UK. Allscripts is headquartered in Chicago, Illinois, the US.

Allscripts Healthcare Solutions Inc (MDRX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Allscripts Healthcare Solutions Inc, Medical Devices Deals, 2012 to YTD 2018 8
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
CarePort Health Raises USD3.8 Million in Venture Financing 10
Partnerships 11
Quintiles Transnational Enters Into Co-Development Agreement With Allscripts Healthcare Solutions 11
Acquisition 12
Allscripts Healthcare Acquires Oasis Medical Solutions 12
Allscripts Healthcare Solutions Inc – Key Competitors 13
Allscripts Healthcare Solutions Inc – Key Employees 14
Allscripts Healthcare Solutions Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 18
Financial Announcements 18
Nov 01, 2018: Allscripts announces third quarter 2018 results 18
Aug 02, 2018: Allscripts announces second quarter 2018 results 20
Feb 16, 2017: Allscripts announces fourth quarter and 2016 full-year results 22
Jan 09, 2017: Allscripts announces record fourth quarter bookings and strong finish to 2016 26
Corporate Communications 27
Sep 06, 2017: Surescripts and Allscripts Join Forces to Make Patient Medication History Data Available to Pharmacists in the Wake of Hurricane Harvey 27
Government and Public Interest 29
Oct 30, 2018: First-ever Chicago-Israel Health Tech summit opens door to U.S. market for 20 of Israel’s most promising health tech startups 29
Jan 30, 2017: Allscripts open ecosystem enables more than 2 billion data shares, continues to lead industry in innovation, data sharing and connectivity 30
Product News 31
Nov 15, 2017: Allscripts to deliver anesthesiology solution at the Royal Adelaide Hospital 31
Apr 26, 2017: Concentra to launch Allscripts Practice Management for optimal efficiency and productivity 32
Other Significant Developments 33
Aug 13, 2018: Allscripts open ecosystem drives healthcare data interoperability 33
Sep 20, 2017: PainCAS now available for Allscripts users: A pain and opioid risk assessment featuring SOAPP & COMM 34
Sep 14, 2017: Surescripts and Allscripts Expand Emergency Service to Make Patient Medication History Data Available to Pharmacists in the Wake of Hurricane Irma 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Allscripts Healthcare Solutions Inc, Medical Devices Deals, 2012 to YTD 2018 8
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CarePort Health Raises USD3.8 Million in Venture Financing 10
Quintiles Transnational Enters Into Co-Development Agreement With Allscripts Healthcare Solutions 11
Allscripts Healthcare Acquires Oasis Medical Solutions 12
Allscripts Healthcare Solutions Inc, Key Competitors 13
Allscripts Healthcare Solutions Inc, Key Employees 14
Allscripts Healthcare Solutions Inc, Other Locations 15
Allscripts Healthcare Solutions Inc, Subsidiaries 16

List of Figures
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Allscripts Healthcare Solutions Inc, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[Allscripts Healthcare Solutions Inc (MDRX):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bionomics Ltd (BNO)-製薬・医療分野:企業M&A・提携分析
    Summary Bionomics Ltd (Bionomics) is a biopharmaceutical company that focuses on the development of treatments for cancer, and central nervous system disorders such as anxiety, depression and Alzheimer's disease. Its pipeline products include BNC210, BNC 105, BNC101, and BNC375. The company uses var …
  • Nuformix Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Nuformix Ltd (Nuformix) is a provider of pharmaceutical cocrystallisation products. The company develops and manufactures products in reprofiling, supergenerics and emerging markets areas. It offers methodologies for rational solid form discovery; and provides technologies for rapid solid fo …
  • ORChem Co., Ltd.:企業のM&A・事業提携・投資動向
    ORChem Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ORChem Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Oxford Nanopore Technologies Ltd:企業の戦略的SWOT分析
    Oxford Nanopore Technologies Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Daiwa Securities Group Inc:企業の戦略・SWOT・財務分析
    Daiwa Securities Group Inc - Strategy, SWOT and Corporate Finance Report Summary Daiwa Securities Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • 88 Energy Ltd (88E):石油・ガス:M&Aディール及び事業提携情報
    Summary 88 Energy Ltd (88 Energy), formerly Tangiers Petroleum Ltd, is an exploration and production company that develops oil-rich provinces. The company offers discovery, exploration and development of onshore oil projects. It has oil and gas assets in Morocco and Australia. 88 Energy’s Morocco pr …
  • Ingram Micro Inc:企業の戦略的SWOT分析
    Ingram Micro Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • TIS Inc (3626):企業の財務・戦略的SWOT分析
    TIS Inc (3626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Lassila & Tikanoja plc:企業のM&A・事業提携・投資動向
    Lassila & Tikanoja plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lassila & Tikanoja plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • The Advisory Board Company:企業の戦略的SWOT分析
    The Advisory Board Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Condor Petroleum Inc (CPI)-石油・ガス分野:企業M&A・提携分析
    Summary Condor Petroleum Inc. (Condor) is an independent upstream oil and gas company. The company through its subsidiaries, acquires, explores, produces and markets oil and gas. It has operational presence in Kazakhstan and Turkey. The company operates on the Pre-Caspian basin, a prolific region th …
  • LivePerson, Inc. (LPSN):企業の財務・戦略的SWOT分析
    LivePerson, Inc. (LPSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • K&H Bank Zrt:企業の戦略・SWOT・財務情報
    K&H Bank Zrt - Strategy, SWOT and Corporate Finance Report Summary K&H Bank Zrt - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • ZAD Bulstrad Vienna Insurance Group:企業の戦略・SWOT・財務分析
    ZAD Bulstrad Vienna Insurance Group - Strategy, SWOT and Corporate Finance Report Summary ZAD Bulstrad Vienna Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Meiji Holdings Co Ltd (2269):企業の財務・戦略的SWOT分析
    Meiji Holdings Co Ltd (2269) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Medherant Ltd:企業の製品パイプライン分析
    Summary Medherant Ltd (Medherant) is a transdermal drug delivery patch company. The company develops and commercializes novel technologies for delivery of drugs through the skin using expertise in bioadhesives and polymer chemistry to treat pain, Alzheimer's disease, and for smoking cessation, hormo …
  • Europa Oil & Gas (Holdings) Plc (EOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Europa Oil & Gas (Holdings) Plc (Europa Oil) is an oil and gas company that offers exploration and development services. The company's services include production and development of conventional and unconventional hydrocarbon assets. It operates its assets in East Midlands basin, Aquitain ba …
  • Calithera Biosciences Inc (CALA):製薬・医療:M&Aディール及び事業提携情報
    Summary Calithera Biosciences Inc (Calithera) is a clinical-stage bio-pharmaceutical company that discovers and develops novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. The company’s product pipeline includes CB-839, a glutaminas …
  • South Jersey Industries, Inc. (SJI):電力:M&Aディール及び事業提携情報
    Summary South Jersey Industries, Inc. (SJI) is an energy services holding company that sources and supplies natural gas and electricity. It develops, owns, and operates on-site energy production facilities. The company provides wholesale commodity marketing and fuel management services; and also off …
  • Lechwerke AG (LEC):企業の財務・戦略的SWOT分析
    Summary Lechwerke AG (LechWerke), a subsidiary of Innogy SE is a utility service provider that offers electricity products natural gas products and energy services. The company provides services such as electrical safety, gas safety, energy monitoring, power plant contracting, street lighting, energ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆